The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin*

Abstract

These data indicate that in addition to the liver, the intestine is a major site of the interaction between oral midazolam and clarithromycin. Interindividual variability in first-pass extraction of high-affinity CYP3A substrates such as midazolam is primarily a function of intestinal enzyme activity.